Home/Filings/4/0001209191-21-070819
4//SEC Filing

O'Byrne Jason 4

Accession 0001209191-21-070819

CIK 0001619856other

Filed

Dec 20, 7:00 PM ET

Accepted

Dec 21, 5:35 PM ET

Size

5.5 KB

Accession

0001209191-21-070819

Insider Transaction Report

Form 4
Period: 2021-12-20
O'Byrne Jason
Chief Financial Officer
Transactions
  • Award

    Option to purchase Common Stock

    2021-12-20+147,000147,000 total
    Exercise: $15.16Exp: 2031-12-19Common Stock (147,000 underlying)
Footnotes (1)
  • [F1]The shares subject to this option will vest in equal monthly installments starting on the first monthly anniversary of the grant date until the option is fully vested on December 20, 2025, subject to the reporting person's continued service to the Issuer through the applicable vesting dates.

Issuer

Caribou Biosciences, Inc.

CIK 0001619856

Entity typeother

Related Parties

1
  • filerCIK 0001871145

Filing Metadata

Form type
4
Filed
Dec 20, 7:00 PM ET
Accepted
Dec 21, 5:35 PM ET
Size
5.5 KB